Abstract

BackgroundThe immunomodulatory effects of granulocyte colony-stimulating factor (G-CSF) on T cells result in a low incidence of acute graft-versus-host disease (aGVHD) in G-CSF-mobilized allogeneic peripheral blood stem cell transplantation (G-PBSCT). However, the exact mechanism remains unclear. Regulatory γδ T cells (γδTregs), characterized by the presence of TCRγδ and Foxp3, have aroused great concern in the maintenance of immune tolerance. We hypothesized that γδTregs might involve in the immunomodulatory effects of G-CSF mobilization.MethodsThe expression and immunomodulatory function of γδTreg subsets in peripheral blood of donors before and after G-CSF treatment in vivo and in vitro were evaluated by flow cytometry and CFSE assays. To investigate the effects of γδTregs on aGVHD, the association between γδTreg subsets in grafts and aGVHD in recipients was estimated.ResultsThe proportions of Vδ1Tregs, CD27+Vδ1Tregs and CD25+Vδ1Tregs were significantly increased in peripheral blood after G-CSF treatment in vivo. γδTregs could be generated in vitro by stimulating with anti-TCRγδ in the presence of G-CSF. The immune phenotype, proliferation suppression function, and cytokine secretion of G-CSF-induced γδTregs were similar to that of transforming growth factor-β (TGF-β)-induced γδTregs. The clinical data demonstrated that the proportion of CD27+Vδ1Tregs in grafts was significantly lower in the patients who experienced aGVHD than in those who did not develop aGVHD (P = 0.028), and the proportions of other γδTreg subsets in grafts did not differ significantly between the two groups. The best cutoff value for CD27+Vδ1Treg proportion in grafts in prediction of aGVHD was 0.33%, with an area under the curve value of 0.725 (P = 0.043). Eight patients (26.7%) were classified as the low-CD27+Vδ1Treg group (< 0.33%), and 22 patients (73.3%) as the high-CD27+Vδ1Treg group (≥ 0.33%). The incidence of aGVHD was higher in the low-CD27+Vδ1Treg group than in the high-CD27+Vδ1Treg group (75.0% versus 22.7%, P = 0.028).ConclusionsG-CSF could induce the generation of γδTregs in vivo and in vitro, and γδTregs might participate in aGVHD regulation in G-PBSCT.

Highlights

  • The immunomodulatory effects of granulocyte colony-stimulating factor (G-CSF) on T cells result in a low incidence of acute graft-versus-host disease in G-CSF-mobilized allogeneic peripheral blood stem cell transplantation (G-PBSCT)

  • We investigated the effects of G-CSF on regulatory γδ T cells (γδTregs) in vivo and in vitro, and explored the role of γδTregs in acute graft-versus-host disease (aGVHD) in G-PBSCT recipients

  • G‐CSF induces γδTregs in vivo To investigate the effects of G-CSF on γδTregs, the proportions of total γδ, Vδ1, and Vδ2 T cells were first compared in Peripheral blood (PB) from 30 donors before and after G-CSF treatment in vivo

Read more

Summary

Introduction

The immunomodulatory effects of granulocyte colony-stimulating factor (G-CSF) on T cells result in a low incidence of acute graft-versus-host disease (aGVHD) in G-CSF-mobilized allogeneic peripheral blood stem cell transplantation (G-PBSCT). Our previous study has documented that G-CSF might change the distribution and clonality of the T cell receptors (TCRs) on γδ T cells, and this alteration might play a role in mediating GVHD in G-PBSCT [17]. Based on these results, we hypothesize that a possible mechanism of G-CSF inducing immune tolerance in G-PBSCT is that G-CSF induces γδTregs in grafts. We investigated the effects of G-CSF on γδTregs in vivo and in vitro, and explored the role of γδTregs in aGVHD in G-PBSCT recipients

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call